Editas Medicine Appoints Akshay Vaishnaw, M.D., Ph.D., to its Board of Directors
July 29, 2016 08:00 ET
|
Editas Medicine
CAMBRIDGE, Mass., July 29, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today the appointment of Akshay Vaishnaw, M.D., Ph.D., to its...